Navigation Links
Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/5/2009

tigator, Thomas J. Louie, M.D., presented top-line data from Optimer's fidaxomicin North American Phase 3 clinical study for patients with Clostridium difficile infection at the European Congress of Clinical Microbiology and Infectious Diseases meeting, which showed the trial met its primary endpoint of achieving clinical cure compared to Vancocin(R). In addition, the top-line data showed that patients treated with fidaxomicin experienced a reduction in CDI recurrence compared to Vancocin (p=0.004) and had a higher global cure (cure with no recurrence within four weeks) compared to Vancocin (p=0.006).
  • Clinical investigator, Mark A. Miller, M.D., presented additional data from Optimer's fidaxomicin North American Phase 3 clinical study at the Digestive Disease Week 2009 Conference focusing on patient risk factors believed to be predictive of CDI recurrence following treatment. These risk factors include albumin levels, white blood cell (WBC) count and temperature and strain types of CDI. The data showed that fidaxomicin overall demonstrated a lower recurrence rate compared to Vancocin (p=0.004) regardless of albumin levels, WBC count and temperature, as well as for patients with non-BI (NAP1/027) strains.
  • The United States Patent and Trademark Office issued Optimer a production patent covering steps used in the manufacture of fidaxomicin.
  • About Optimer Pharmaceuticals

    Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. Fidaxomicin, formerly known as OPT-80, is the only antibiotic therapy currently in Phase 3 worldwide clinical development for Clostridium difficile infection. Prulifloxacin is an antibiotic which has completed t
    '/>"/>

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference
    2. Optimer Pharmaceuticals to Present at June 2009 Investor Conferences
    3. Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI
    4. Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
    5. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
    6. Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update
    7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT
    8. Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist
    9. Shanghai ChemPartner and ELARA Pharmaceuticals Expand Drug Discovery Collaboration to a New Level
    10. Eiger BioPharmaceuticals Acquires Exclusive License to Novel Hepatitis C Virus (HCV) Technology From Stanford University
    11. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/20/2014)... Fla. , Aug. 20, 2014 ... will host a conference call to provide an ... 2014Time:4:30 p.m. Eastern daylight timeDial-in numbers:(888) 505-4369 (U.S. ... 9126599 Live web cast: www.neurotropebioscience.com , under "Investor ... hours after completion through September 2, 2014 at ...
    (Date:8/20/2014)... Francisco, CA (PRWEB) August 20, 2014 ... Conference is being held on October 29-30 in ... perspectives from industry, academic and government researchers and clinicians ... in the space. , In the twelve years ... one hundred therapies have been introduced with pharmacogenetic information ...
    (Date:8/20/2014)... August 20, 2014 WriteResult®, a leading ... that it has expanded its myPROpad™ ePRO tablet with ... one of the most widely used and well-respected ... health status. The EQ-5D is used during clinical trials ... measure that can be used to demonstrate Health-Related Quality ...
    (Date:8/19/2014)... and Markets  has announced the addition of the "Cell and ... their offering. This report analyzes the worldwide markets ... following Product Segments: Media, Sera, and Reagents. The report ... , Japan , Europe , ... . Annual estimates and forecasts are provided for the period 2013 ...
    Breaking Biology Technology:Neurotrope To Host Conference Call 26th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2EQ-5D™ Assessment Now Available for iPad 2Global Cell and Tissue Culture Supplies - Strategic Business Report 2014 2
    ... A sensitive and simple high performance liquid ... simultaneous analysis of the metabolites of four nitrofuran antibiotics in ... Abstract , ... washes, hydrolysis and derivatization followed by liquid-liquid (L-L) extraction before ...
    ... Characterization of nucleotide and nucleoside analogs ... for the first time using liquid chromatography tandem mass ... characterized using nucleotide and nucleoside standards with product and ... were believed to be major active ingredients which have ...
    ... Many pesticides, which are difficult or generally not to analyse by GC/MS, , ... LC/MS/MS. After simple solvent extraction , ... The drawback of MS/MS methods is laborious parameter ... This effort can significantly be reduced by the use , ...
    Cached Biology Technology:High sensitivity quantitation of metabolites of nitrofuran antibiotics in animal tissue using LC/MS/MS 2High sensitivity quantitation of metabolites of nitrofuran antibiotics in animal tissue using LC/MS/MS 3Isolation and Characterization of Anti-Viral Nucleoside Compounds from the Chinese Herb Taraxacum Mongolicum 2Isolation and Characterization of Anti-Viral Nucleoside Compounds from the Chinese Herb Taraxacum Mongolicum 3Simultaneous Determination of Residues of Approximately 100 Pesticides , and Metabolites in Fruit and Vegetables by LC/MS/MS 2Simultaneous Determination of Residues of Approximately 100 Pesticides , and Metabolites in Fruit and Vegetables by LC/MS/MS 3Simultaneous Determination of Residues of Approximately 100 Pesticides , and Metabolites in Fruit and Vegetables by LC/MS/MS 4Simultaneous Determination of Residues of Approximately 100 Pesticides , and Metabolites in Fruit and Vegetables by LC/MS/MS 5Simultaneous Determination of Residues of Approximately 100 Pesticides , and Metabolites in Fruit and Vegetables by LC/MS/MS 6
    (Date:8/21/2014)... might seem easy to ignore, but they are the ... depend upon. Humans are increasingly dependent on algae, too, ... and sink it to the bottom of the ocean. ... laboratory experiments, researchers have evidence showing that viruses infecting ... algae,s blooms, even when all else stays essentially the ...
    (Date:8/21/2014)... BATON ROUGE In a finding that has implications ... and planets elsewhere in the solar system, LSU Associate ... funded by the National Science Foundation, or NSF, this ... sediments of a lake that lies 800 meters (2600 ... sheet support "viable microbial ecosystems.", Given that more than ...
    (Date:8/21/2014)... an international standards process, will be available soon and ... review published in the OnlineFirst version of Nutrition ... journal of the American Society for Parenteral and Enteral ... occurrence of misconnection that can be harmful and even ... to join medical devices, components, and accessories to deliver ...
    Breaking Biology News(10 mins):Viruses take down massive algal blooms, with big implications for climate 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 2800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 3800 meters beneath Antarctic ice sheet, subglacial lake holds viable microbial ecosystems 4New feeding tube connectors will improve patient safety 2
    ... Climate change, a recent hot topic when studying the ... another important factor to this global phenomenon is still ... to see the possible effects of climate change on ... waters, and groundwater are responding to climate change. ...
    ... When the space shuttle Endeavour touched down at ... Medical Branch at Galveston microbiology and immunology department chairman ... to a reunion with some of its passengers. ... were Streptococcus pneumoniae bacteria, members of a species commonly ...
    ... recently physicians have had to rely on time-consuming and ... diseases such as multiple sclerosis, Alzheimer,s and schizophrenia. ... Journal of Neural Engineering suggests that we could soon ... diseases by analysing the tiny magnetic fields produced by ...
    Cached Biology News:Climate change goes underground 2Climate change goes underground 3Shuttle brings space-grown strep bacteria back for study 2Shuttle brings space-grown strep bacteria back for study 360 second test could help early diagnosis of common brain diseases 2
    ... variety of environmental and pathophysiological stressful conditions ... proteins known as heat shock proteins (HSPs), ... (SRPs). The Hsp90 family of proteins ... and beta, Grp94, and Trap-1 (Hsp75). It ...
    ... (AR) Competitor Assay Kits provide a sensitive ... potential AR ligands using fluorescence polarization (FP). ... domain protein tagged with His and GST ... androgen ligand (Fluormone AL Green in the ...
    Custom LNA Oligonucleotide synthesis ,High quality Custom LNA Oligonucleotides are available for a variety of different specialty applications and innovative products. ,Please inquire for further...
    ... - with a modular approach to instrument ... ChemStation Plus NDS family provides modular software ... data management, giving you the flexibility to ... needs now and that can grow as ...
    Biology Products: